Coverage summary
| Indication | Coverage |
|---|---|
| Wegovy (weight loss) | No |
| Zepbound (weight loss) | No |
| Ozempic or Mounjaro (type 2 diabetes) | Yes |
If Illinois Medicaid says no, two cash programs to check.
No insurance needed.
- Strut Health$149 a month, with auto-refillcompounded semaglutideCheck price →You pick Weight Loss, then a five-minute online visit
- Shed$199 a month30% off first month with code Shed10compounded semaglutideCheck price →A health form first, then you choose your plan
Cheapest GLP-1 without insurance compares the three cash routes, and cheapest GLP-1 in Illinois prices each drug that ships there.
A clinical trial costs nothing, and nobody checks your income.
Prior-authorization criteria
These rules come from the state preferred drug list (PDL), the list of drugs Illinois Medicaid has agreed to pay for. Prior authorization means your doctor asks the plan to approve the drug before the pharmacy fills it. Nearly every state covers the diabetes path that way.
| Criterion | Value |
|---|---|
| How hard the approval is | Hard |
| BMI threshold (weight-loss path) | Not applicable (weight-loss path not covered) |
| Last PDL update reviewed | July 1, 2026 |
If the plan denies it, the appeal letter templates cover the reasons plans give and what to send back.
What Illinois Medicaid paid for GLP-1s
Illinois Medicaid reported 23,401 GLP-1 prescriptions to CMS in 2025's last quarter and paid pharmacies $25.0 million.
Counts Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda and Rybelsus, in fee-for-service and managed care, before rebates. CMS blanks its smallest rows, so the real figures are higher. Source: CMS State Drug Utilization Data.
What this means in practice
Illinois Medicaid does not cover GLP-1s for weight loss. The state drug list effective July 1, 2026 has none on it. The Medicaid health plans exclude them too. If you read that Illinois added coverage in 2024, that was the state employee plan. Different program, easy to mix up. Type 2 diabetes is the one path still open. Ozempic and Mounjaro get covered there, but your doctor has to get the plan to approve it first. That step is called prior authorization.
Managed-care organizations in Illinois
Illinois Medicaid pays private health plans, called managed-care organizations or MCOs, to run its coverage. The state contracts with 6, and these are the 5 largest. An MCO has to cover at least what the state list covers and can add rules of its own. Check your own plan's current rules before you send anything in.
- Blue Cross Community Health Plans
- Meridian Health Plan (Centene)
- Aetna Better Health Illinois
- Molina Healthcare of Illinois
- CountyCare Health Plan
Cash-pay alternatives if Medicaid does not cover you
Illinois Medicaid has no weight-loss path to appeal into, so an appeal will not help here. If you have type 2 diabetes, that path is covered. Otherwise the cash market starts around $149 a month for compounded semaglutide.
If you end up paying cash, the GLP-1 cost guide has what each cash route costs, from the compounded floor to the manufacturer-direct brand prices. Federal law bars manufacturer savings cards for anyone on Medicaid.
If a supply gap rather than cost is blocking your refill, the GLP-1 shortage tracker shows which formulations the FDA lists as in shortage now. And if you are 65 or older and also have Medicare, the senior GLP-1 hub lays out the Medicare coverage paths for dual-eligible patients.
For the full cash-pay picture specific to Illinois, see the cheapest GLP-1 in Illinois guide.
30 GLP-1 clinical trials are recruiting in Illinois, and a study supplies its own study medication. Every site is listed on GLP-1 clinical trials in Illinois.
Illinois Medicaid GLP-1 FAQ
Does Illinois Medicaid cover Wegovy for weight loss?
Does Illinois Medicaid cover Zepbound for weight loss?
Does Illinois Medicaid cover Ozempic or Mounjaro for diabetes?
What if Illinois Medicaid does not cover my GLP-1?
Other state Medicaid pages
See the full 51-state coverage table for the side-by-side view across every US state.
How we built this page
Compiled from each state Medicaid's published preferred drug list, PA criteria and PDL committee minutes. State Medicaid programs are not federally required to cover obesity drugs; the diabetes indication is covered nearly everywhere with PA. State-level data is point-in-time and shifts each PDL cycle. Always verify with your state Medicaid plan before relying on this page.
Checked August 24, 2026. We check each state Medicaid PDL and PA criteria quarterly. If you have recently had a different experience with Illinois Medicaid, email hello@glpchart.com with the details and we will check it.